Variational AI

Transforming drug discovery with generative AI Founded in 2019, Variational AI is pioneering a new era of small molecule drug discovery by leveraging a powerful new form of machine learning known as generative AI. Our mission is to redefine the unit economics of drug discovery, enabling biopharma partners to bring novel therapeutics to patients faster […] From oncology to other high-need therapeutic areas, we are working hand-in-hand with industry partners to unlock new chemical space and accelerate the path to novel therapies. Evolving at the intersection of AI and drug discovery Our team brings together deep expertise across machine learning, medicinal chemistry, and computational chemistry, applied to the challenges of small molecule drug discovery. Our AI scientists have been trained and conducted research at some of the world’s leading academic and industrial laboratories, including MIT, Caltech, Berkeley, Google, Microsoft Research, and D-Wave Quantum, and combine cutting-edge expertise in generative modeling with strong foundations in applied mathematics and computational science. Alongside experienced medicinal and computational chemists with first-hand pharmaceutical R&D…